Cargando…

Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

INTRODUCTION: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. METHODS: We combined drug susceptibility results and molecular strain typing data with treatment outcome reports to assess the influence of drug resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonnet, Maryline, Pardini, Manuela, Meacci, Francesca, Orrù, Germano, Yesilkaya, Hasan, Jarosz, Thierry, Andrew, Peter W., Barer, Mike, Checchi, Francesco, Rinder, Heinz, Orefici, Graziella, Rüsch-Gerdes, Sabine, Fattorini, Lanfranco, Oggioni, Marco Rinaldo, Melzer, Juliet, Niemann, Stefan, Varaine, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160294/ https://www.ncbi.nlm.nih.gov/pubmed/21886778 http://dx.doi.org/10.1371/journal.pone.0023081

Ejemplares similares

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients
por: Merker, Matthias, et al.
Publicado: (2013)

Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis.
por: Niemann, S, et al.
Publicado: (2000)

Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance
por: Cox, Helen, et al.
Publicado: (2006)

Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting
por: Feuerriegel, Silke, et al.
Publicado: (2012)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study
por: Huerga, Helena, et al.
Publicado: (2019)

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
por: Brigden, Grania, et al.
Publicado: (2015)

The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia
por: Cox, Helen Suzanne, et al.
Publicado: (2005)

Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
por: Lanni, Alessio, et al.
Publicado: (2023)

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study
por: Bastard, Mathieu, et al.
Publicado: (2018)

Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
por: Iacobino, Angelo, et al.
Publicado: (2021)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
por: Sanchez-Padilla, Elisabeth, et al.
Publicado: (2012)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada
por: Rocheleau, Genevieve, et al.
Publicado: (2017)

Worldwide Emergence of Extensively Drug-resistant Tuberculosis
por: Shah, N. Sarita, et al.
Publicado: (2007)

Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions
por: Lanni, Alessio, et al.
Publicado: (2022)

Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia
por: Walls, Genevieve, et al.
Publicado: (2015)

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
por: Tadolini, Marina, et al.
Publicado: (2016)

Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013
por: an der Heiden, Maria, et al.
Publicado: (2017)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens
por: Velikova, Nadya, et al.
Publicado: (2016)

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis
por: Heyckendorf, Jan, et al.
Publicado: (2018)

Expression of Proinflammatory and Regulatory Cytokines via NF-κB and MAPK-Dependent and IFN Regulatory Factor-3-Independent Mechanisms in Human Primary Monocytes Infected by Mycobacterium tuberculosis
por: Giacomini, Elena, et al.
Publicado: (2011)

Pathogen-based precision medicine for drug-resistant tuberculosis
por: Gröschel, Matthias I., et al.
Publicado: (2018)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Drug resistance and combating drug resistance in cancer
por: Wang, Xuan, et al.
Publicado: (2019)

Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
por: Cornaglia, G, et al.
Publicado: (1996)

Evaluation of Combined LED-Fluorescence Microscopy and Bleach Sedimentation for Diagnosis of Tuberculosis at Peripheral Health Service Level
por: Bonnet, Maryline, et al.
Publicado: (2011)

Performance of LED-Based Fluorescence Microscopy to Diagnose Tuberculosis in a Peripheral Health Centre in Nairobi
por: Bonnet, Maryline, et al.
Publicado: (2011)

Occupational risk of tuberculosis transmission in a low incidence area
por: Diel, Roland, et al.
Publicado: (2005)

Streptococcus pneumoniae: ‘captain of the men of death’ and financial burden
por: Yesilkaya, Hasan, et al.
Publicado: (2022)

Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative Pulmonary Tuberculosis in a HIV Prevalent Setting
por: Huerga, Helena, et al.
Publicado: (2012)

Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis
por: Yakhelef, Nadia, et al.
Publicado: (2020)

Significant Differences Characterise the Correlation Coefficients between Biocide and Antibiotic Susceptibility Profiles in Staphylococcus aureus
por: Oggioni, Marco R, et al.
Publicado: (2015)

Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests
por: Ardizzoni, E., et al.
Publicado: (2021)

Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing
por: Al-Ghafli, Hawra, et al.
Publicado: (2018)

Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia
por: Engström, Anna, et al.
Publicado: (2019)

Drug hypersensitivity in drug-resistant tuberculosis
por: Katran, Zeynep Yegin, et al.
Publicado: (2023)

Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
por: Kim, Chang-Ki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_62vrimr278r1pn111hjb59pg5g